Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04929 |
| Species: | Homo sapiens |
| Position : | chr14:72448647-72451627 |
| Year: | 2026 |
| Title: | Mendelian randomization facilitates identification of schizophrenia risk enhancer RNAs. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Schizophrenia |
| PMID: | 41276612 |
| MONDO: | MONDO:0005090 |
| Cell Source: | SK-N-SH |
| CVCL ID: | CVCL_0531 |
| Cell Type: | neuroblastoma cell |
| Experiment Type: | Enhancer RNA functional perturbation assay; Transcriptome assay; Neuronal differentiation assay |
| High Throughput Method: | RNA-seq; eQTL analysis |
| Low Throughput Method: | RGS6e forward/reverse-complement transcript overexpression; lentiviral transduction; ATRA-induced neuronal differentiation; fluorescence microscopy; neurite-length quantification; plasmid direct sequencing |
| Target gene : | NA |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04946 | chr14:72448647-72451627 | dorsolateral prefrontal cortex | NA | Schizophrenia |